NextPharma Technologies, headquartered in the UK and founded in 2000, is a leading provider of product development, contract manufacturing and distribution outsourcing services to the pharmaceutical, specialty pharmaceutical, generics and biotech industry. It offers a broad range of services from early phase product development to high volume commercial lyophilization and manufacturing with specific expertise in analytics and clinical trial supplies. NextPharma operates globally with five product development centres, seven manufacturing plants and five logistics sites across Europe and North America. Across these locations NextPharma has built-up a strong track record in the development and manufacture of cytotoxics, hormones, antibiotics, pellets, sterile, solid, semi-solid, liquid, fill finish and dry dosage forms, supplying customers in North America, Europe and Japan.
About BioLife Solutions
BioLife Solutions develops and markets patented hypothermic storage and
cryopreservation media products for cells, tissues, and organs. The
Company's proprietary HypoThermosol(R) and CryoStor(TM) platform of
preservation media products are marketed to academic research institutions,
clinical care provider organizations, and commercial companies involved in
cell therapy, tissue engineering, cord blood banking, drug discovery, and
toxicology testing. BioLife's products ar
|SOURCE BioLife Solutions Inc.|
Copyright©2007 PR Newswire.
All rights reserved